OMB APPROVAL
FORM 3 ----------------------------
OMB Number: 3235-0104
Expires: December 31, 2001
Estimated average burden
hours per response.......0.5
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
(Print or Type Responses)
________________________________________________________________________________
1. Name and Address of Reporting Person*
SmithKline Beecham plc
--------------------------------------------------------------------------------
(Last) (First) (Middle)
New Horizons Court, Brentford
--------------------------------------------------------------------------------
(Street)
Middlesex TW8 9EP, England
--------------------------------------------------------------------------------
(City) (State) (Zip)
________________________________________________________________________________
2. Date of Event Requiring Statement (Month/Day/Year)
10/7/00
________________________________________________________________________________
3. IRS Identification Number of Reporting Person, if an Entity (Voluntary)
________________________________________________________________________________
4. Issuer Name and Ticker or Trading Symbol
Block Drug Company, Inc. (BLOCA)
________________________________________________________________________________
5. Relationship of Reporting Person to Issuer
(Check all applicable)
[_] Director [X] 10% Owner
[_] Officer (give title below) [_] Other (specify below)
________________________________________________________________________________
6. If Amendment, Date of Original (Month/Day/Year)
________________________________________________________________________________
7. Individual or Joint/Group Filing (Check applicable line)
[_] Form Filed by One Reporting Person
[X] Form Filed by More than One Reporting Person
<PAGE>
================================================================================
Table I -- Non-Derivative Securities Beneficially Owned
================================================================================
<TABLE>
3. Ownership Form:
2. Amount of Securities Direct (D) or
1. Title of Security Beneficially Owned Indirect (I) 4. Nature of Indirect Beneficial Ownership
(Instr. 4) (Instr. 4) (Instr. 5) (Instr. 4)
------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
Class A Common Stock, par value
$.10 per share 0 shares(1) Not applicable Not applicable
------------------------------------------------------------------------------------------------------------------------------------
Class B Common Stock, par value
$.10 per share 0 shares(1) Not applicable Not applicable
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
====================================================================================================================================
</TABLE>
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
* If the Form is filed by more than one Reporting Person, see Instruction
5(b)(v).
Potential persons who are to respond to the collection of Information
contained in this form are not required to respond unless the
form displays a currently valid OMB control number.
------------
(1) See Explanation of Responses.
Page 1 of 4
<PAGE>
FORM 3 (continued)
Table II -- Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
================================================================================
<TABLE>
5. Owner-
3. Title and Amount of Securities ship
Underlying Derivative Security Form of
2. Date Exercisable (Instr. 4) Derivative
and Expiration Date --------------------------------- 4. Conver- Security:
(Month/Day/Year) Amount sion or Direct 6. Nature of
---------------------- or Exercise (D) or Indirect
Date Expira- Number Price of Indirect Beneficial
1. Title of Derivative Exer- tion of Derivative (I) Ownership
Security (Instr. 4) cisable Date Title Shares Security (Instr. 5) (Instr. 5)
------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C>
Not applicable.
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
====================================================================================================================================
</TABLE>
Explanation of Responses:
See Attachment B
** Intentional misstatements or omissions of facts constitute Federal Criminal
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB Number.
SMITHKLINE BEECHAM PLC
/s/ James Ford 10/17/00
--------------------------------------- ------------------
**Signature of Reporting Person Date
By: Name: James Ford
Title: Attorney-in-fact
SB ACQUISITION CORP.
/s/ Donald F. Parman 10/17/00
--------------------------------------- ------------------
**Signature of Reporting Person Date
By: Name: Donald F. Parman
Title: Assistant Secretary
Page 2 of 4
<PAGE>
Attachment A
------------
Additional Reporting Person
SB Acquisition Corp., a New Jersey corporation, located at One Franklin Plaza,
200 N. 16th Street, Philadelphia, Pennsylvania 19101, is a wholly-owned
subsidiary of SmithKline Beecham plc and joins SmithKline Beecham plc as a filer
for purposes of this Form 3.
Page 3 of 4
<PAGE>
Attachment B
------------
Explanation of Responses
SmithKline Beecham plc ("Parent") and its wholly-owned subsidiary, SB
Acquisition Corp. ("Subsidiary"), entered into a Voting and Tender Agreement
dated October 7, 2000 with certain shareholders of Block Drug Company, Inc.
pursuant to which Parent and Subsidiary have beneficial ownership of certain
shares of Class A common stock and Class B common stock of Block Drug Company,
Inc., but do not have a pecuniary interest in such shares.
Page 4 of 4